These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17562516)

  • 21. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
    van Vugt JM; van Zalen-Sprock RM; Kostense PJ
    Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does nuchal translucency have a role in fetal cardiac screening?
    Hyett J
    Prenat Diagn; 2004 Dec; 24(13):1130-5. PubMed ID: 15614845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
    Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-trimester screening: an overview.
    Eiben B; Glaubitz R
    J Histochem Cytochem; 2005 Mar; 53(3):281-3. PubMed ID: 15750002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of thickened nuchal fold with fetal chromosomal abnormalities among 919 cases].
    Ma L; Luo Y; Rong L; Huo P; Gao J; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep; 36(9):874-876. PubMed ID: 31515779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001].
    Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V;
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nuchal translucency: technical measurement and value].
    Broussin B; Sarramon MF
    J Radiol; 2002 Dec; 83(12 Pt 2):1891-8. PubMed ID: 12592151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
    Montenegro N; Matias A; Areias JC; Castedo S; Barros H
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-trimester screening for chromosomal abnormalities.
    Nicolaides KH
    Semin Perinatol; 2005 Aug; 29(4):190-4. PubMed ID: 16104667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.